Thu. 9 May 2024, 5:28pm ET
Benzinga
Earnings, Earnings Misses, News
Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 13.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $230.000 thousand which missed the analyst consensus estimate of $585.000 thousand by 60.68 percent. This is a 5.65K percent increase over sales of $4.000 thousand the same period last year.